Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for growth and bone abnormalities in children with Noonan syndrome
2016-000647-14Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Noonan syndrome comparing Simvastatin with Placebo (2 arms). Primary endpoint: Change in serum IGF-1 z-score. Started Mar 2016; status: completed.
02
Drugs
simvastatin
03
Conditions
Noonan syndrome
Beyond the preview
Go deeper on 2016-000647-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000647-14.